Urological Devices | Market Insights | Europe | 2021
Despite the impact of the ongoing COVID-19 pandemic, the European urological device market will grow marginally through 2029. Revenue growth will be driven by ongoing product innovation and an increasing aging population and an associated rise in cases of urological diseases such as UI, stones, BPH, prostate and bladder cancer, and ED; however, the market will be negatively affected in the short term by the global COVID-19 pandemic, limited capital equipment budgets among European health care facilities, and prevailing preferences for established treatment methods will hinder the adoption of newer, premium-priced technology to some degree, hampering overall market growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for urological devices in France, Germany, Italy, Spain, and the UK across a 10-year period.
